Traws Pharma Inc.

Traws Pharma Inc. annual/quarterly operating income history and growth rate from 2011 to 2025. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.

• Traws Pharma Inc. operating income for the quarter ending June 30, 2025 was -1.2 M, a 98.99% decrease year-over-year.
• Traws Pharma Inc. operating income for the twelve months ending June 30, 2025 was -138.3 M, a 557.24% increase year-over-year.
• Traws Pharma Inc. annual operating income for 2025 was -17.9 M, a 87.45% decrease from 2024.
• Traws Pharma Inc. annual operating income for 2024 was -142.4 M, a 601.42% increase from 2023.
• Traws Pharma Inc. annual operating income for 2023 was -20.3 M, a 3.42% increase from 2022.
• Traws Pharma Inc. annual operating income for 2022 was -19.6 M.